The salivary microbiota as a diagnostic indicator of oral cancer: A descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects
© Mager et al; licensee BioMed Central Ltd. 2005
Received: 22 February 2005
Accepted: 7 July 2005
Published: 7 July 2005
The purpose of the present investigation was to determine if the salivary counts of 40 common oral bacteria in subjects with an oral squamous cell carcinoma (OSCC) lesion would differ from those found in cancer-free (OSCC-free) controls.
Unstimulated saliva samples were collected from 229 OSCC-free and 45 OSCC subjects and evaluated for their content of 40 common oral bacteria using checkerboard DNA-DNA hybridization. DNA counts per ml saliva were determined for each species, averaged across subjects in the 2 subject groups, and significance of differences between groups determined using the Mann-Whitney test and adjusted for multiple comparisons. Diagnostic sensitivity and specificity in detection of OSCC by levels of salivary organisms were computed and comparisons made separately between a non-matched group of 45 OSCC subjects and 229 controls and a group of 45 OSCC subjects and 45 controls matched by age, gender and smoking history.
Counts of 3 of the 40 species tested, Capnocytophaga gingivalis, Prevotella melaninogenica and Streptococcus mitis, were elevated in the saliva of individuals with OSCC (p < 0.001). When tested as diagnostic markers the 3 species were found to predict 80% of cancer cases (sensitivity) while excluding 83% of controls (specificity) in the non-matched group. Diagnostic sensitivity and specificity in the matched group were 80% and 82% respectively.
High salivary counts of C. gingivalis, P. melaninogenica and S. mitis may be diagnostic indicators of OSCC.
KeywordsOral Squamous Cell Carcinoma Oral mucosa bacterial markers bacteria early detection
Each year nearly 30,000 Americans are diagnosed with oral cancer. 90% of these lesions are oral squamous cell carcinomas . Despite advances in surgery, radiation and chemotherapy, the five-year survival rate is 54%, one of the lowest of the major cancer sites, and this rate has not improved significantly in recent decades [2–4]. Worldwide, the problem is much greater, with over 350,000 to 400,000 new cases being found each year . The disease kills one person every hour – more people than cancers of the cervix, brain, ovary, testes, liver, kidney, malignant melanoma or Hodgkin's lymphoma [5, 6]. In the United States, African American males suffer the highest incidence and lowest survival rates of any group. From 1985 to 1996, the five-year survival rate for tongue carcinoma in African-American men was 27%, compared with a 47% five-year survival rate among white men . In 2001, similar five-year survival rates were found in a study of oral and pharyngeal cancer among African-American and White men . Notably, incidence in young adults (<40 years) is increasing in the U.S. [9, 10] and worldwide [11, 12].
Early detection followed by appropriate treatment, can increase cure rates to 80 or 90%, and greatly improve the quality of life by minimizing extensive, debilitating treatments [5, 13]. Despite the accessibility of the oral cavity to direct examination, these malignancies are often not detected until a late stage [5, 14, 15]. Oral cancer is unusual in that it carries a high risk of second primary tumors. Patients who survive a first cancer of the oral cavity have up to a 20-fold increased risk of developing a second primary oral cancer and that risk lasts 5–10 years and sometimes longer .
Major risk factors for oral cancers in the United States are use of tobacco and alcohol, which account for 75 to 80% of all oral cancers [5, 17]. Although tobacco is a well-recognized risk factor for OSCC, the public is generally unaware that alcohol synergizes with tobacco. Those who both smoke and drink have 15 times the risk of developing oral cancer . Notably, some oral cancer patients have no known risk factors, and the disease in this population may pursue a particularly aggressive course .
The American Cancer Society recommends that doctors and dentists examine the mouth and throat during routine examinations  as early cancer lesions are often asymptomatic and may mimic benign lesions [19, 20]. General population screening, however, has not been shown to reduce the incidence of and mortality from oral cancer. The reasons include the low prevalence and incidence of OSCC, the potential for false-positive diagnoses and poor compliance with screening and referral [6, 21]. Thus the National Institute of Dental and Craniofacial Research and The Oral Cancer Foundation have recommended that research efforts focus on developing novel detection techniques [5, 16].
Studies have reported that certain common oral bacteria are elevated on or in oral and esophageal cancer lesions and their associated lymph nodes [22–28]. Although increased colonization of facultative oral streptococci have been reported most often [24–27], anaerobic Prevotella, Veillonella, Porphyromonas and Capnocytophaga species were also elevated [25, 26, 28]. Currently, studies are examining whether bacteria may be incidentally or causally associated with oral cancer. Additional research is determining whether various salivary markers may be used as early diagnostic indicators for oral cancer.
The reason for these shifts in bacterial colonization of cancer lesions is unclear. Mechanistic studies of bacterial attachment provide some insights, however. Research has repeatedly shown that oral bacteria demonstrate specific tropisms toward different biological surfaces in the oral cavity such as the teeth, mucosa, and other bacteria [29–35]. The non-shedding surfaces of the teeth offer a far different habitat than the continually shedding surfaces of the oral mucosa. Due to the repeated shedding of epithelial cells, there is less time for a complex biofilm to develop on soft tissue surfaces; thus, a premium is placed on potent mechanisms of adhesion. The differences in bacterial tropisms for specific oral sites suggest that different intra-oral surfaces and bacterial species have different receptors and adhesion molecules that dictate the colonization of different oral surfaces.
It is now recognized that bacteria bind to and colonize mucosal surfaces in a highly selective manner via a "lock- and key" mechanism. Adhesins on bacteria bind specifically to complementary receptors on the mucosal surfaces of the host. These adhesins differ from species to species leading to specificity in attachment to different surfaces. Studies have shown that even within genera, colonization patterns of individual species may differ markedly [29–32]. Streptococcus salivarius, for example, preferentially colonized the oral soft tissues and saliva compared to the teeth, while the reverse was true of Streptococcus sanguis.
Cancer has been referred to as a molecular disease of cell membrane glycoconjugates, [36–38]. Certain glycoconjugates serve as receptors for specific bacteria and recent reports support the notion that shifts in the colonization of different cancer cells are associated with observed changes in cell surface receptors [36, 40, 41]. An in vitro study of S. sanguis, a common oral inhabitant, demonstrated that its binding capacity to normal exfoliated human buccal epithelial cells (HBEC) depended upon the availability of surface sialic acid residues . Desialylation of HBEC invariably abolished adhesion of S. sanguis to these epithelial cells. In similar experiments carried out with a buccal carcinoma cell line, S. sanguis did not reliably attach. It was determined that the tumor cells did not express the sialylated membrane glycoprotein of normal cells suggesting that changes in the surface receptors had occurred in the buccal carcinoma cell line.
In a previous study of 225 OSCC-free subjects we found a high degree of specificity in the "preferred" intra-oral localization of species, even within a single genus such as Streptococcus . This specificity in localization of individual species agreed with that described in previous studies. Our investigation extended earlier findings by describing the distribution of multiple species within the same genus on a wider range of intra-oral surfaces. For example, S. oralis, S. constellatus, S. mitis, S. intermedius and S. anginosus colonized the soft tissues in higher proportions than the teeth; however, their "preferred" soft tissue habitats differed. S. sanguis colonized different soft tissue locations in similar proportions, but was found in higher mean proportions on the teeth, particularly in the supragingival plaque.
The availability of a large amount of data from the OSCC-free subjects permitted this group to be subset according to periodontal and smoking status and the colonization patterns on the soft tissues compared among groups . The clinical parameters among the populations were in accord with those found in previous studies and results were similar to previous investigations [44–47]. Few differences were found in the salivary or soft tissue microbiota among the subset populations. It was concluded that the presence or absence of periodontal infections or a smoking habit had minimal effects on salivary and soft tissue colonization. These findings were in accord with studies by Danser et al. 1996 and Lie et al. 1998 [48, 49] but contrasted with earlier reports by Colman et al. 1976 and van Winkelhoff et al. 1986 [50, 51]. Importantly, we found that when the microbiota of teeth, soft tissues and saliva were compared, the microbial profile of saliva was similar to that of the soft tissues, but saliva and soft tissue colonization differed markedly from that of dental plaque. These findings were similar to those of other investigations [46, 51, 52].
As previously mentioned, studies have reported that the microbiota of OSCC lesions differs from that found on the soft tissues of OSCC-free individuals. Little was known, however, about the salivary microbiota of oral cancer subjects. Thus, the purpose of the present investigation was to determine whether the salivary microbiota in subjects with an oral squamous cell carcinoma (OSCC) lesion would differ from that found in OSCC-free controls.
Materials and methods
A total of 229 OSCC-free subjects were recruited from the patient pool at The Forsyth Institute. All subjects were 18 years or older, and immunocompetent. Exclusion criteria included: antibiotic therapy within the previous 3 months, pregnancy or lactation, systemic conditions associated with immune dysfunction (e.g., diabetes), previous chemotherapy or radiation and the presence of any oral mucosal lesions.
Oral Cancer Population
Age, gender and smoking status of 229 OSCC-free and 45 OSCC subjects.
Mean Age (±SEM)
% Males (N)
% Smokers (N)
Age, gender and smoking status of 45 OSCC-free and 45 OSCC subjects matched by age, gender and smoking history
Age Mean (±SEM)
Collection of samples and preparation of test membranes
The 40 test strains employed for the development of DNA probes.
43718 and 29523
Actinomyces naeslundii genospecies 1
Actinomyces naeslundii genospecies 2
Fusobacterium nucleatum ss nucleatum
Fusobacterium nucleatum ss polymorphum
Fusobacterium nucleatum ss vincentii
11827 and 11828
45 OSCC-free controls were matched by computer for age, gender and smoking history with the 45 OSCC subjects. Diagnostic sensitivity and specificity for detection of oral cancer using levels of salivary bacteria were computed as described above. The results for the matched population were similar to those for the unmatched comparisons namely that the increased counts of C. gingivalis, P. melaninogenica and S. mitis were 80% diagnostically sensitive and 82% diagnostically specific for the presence of OSCC (Figure 3). As before, the remaining 37 species did not improve sensitivity or specificity.
Results from this investigation demonstrated that oral cancer subjects had elevated counts (p < 0.001) of C. gingivalis, P. melaninogenica and S. mitis in saliva compared to OSCC-free subjects. These results are borderline in significance after adjusting for multiple comparisons. However, when each species was ≥0.4 × 105 they indicated the presence of an OSCC lesion with 80% diagnostic sensitivity and ≥82% specificity in both matched and unmatched populations.
The reason for this finding is unclear. One explanation may relate to the altered cell surface receptors observed in cancer cells [36, 39, 41]. It seems reasonable that alterations in tumor cell receptors could change the adhesion of certain species of bacteria. This was shown, as previously discussed, in an in vitro study of HBEC and buccal cell carcinoma cell lines using the common oral bacterium S. sanguis by Neeser . One might expect that as Neeser found decreased colonization of S. sanguis, a similar study using S. mitis would result in a reduced colonization of oral cancer cells. Interestingly, our previous investigation of 225 OSCC-free subjects provided evidence to the contrary. Colonization of different oral sites differed among the 40 test species, even among those of the same genera, such as streptococci. For example, S. sanguis and S. mitis both colonized the oral soft and hard tissues; however, marked differences in their proportions at these sites were noted. Highly species-specific oral colonization by streptococci has been reported by other investigators [29–32, 57, 58].
Saliva was found to be similar in microbial profile to the soft tissues. This was a significant finding from the study of the OSCC-free population. In contrast, the microbiota of the teeth and saliva differed markedly. These results agreed with previous studies [30, 57, 58]. Thus, if alterations in bacterial adhesion to OSCC cells observed in vitro exist in vivo, colonization of OSCC lesions would be affected. Shifts in the soft tissue microbiota of the oral cavity appear likely to affect salivary levels as well.
A screening test for oral cancer based on salivary counts of bacterial species is appealing. Saliva is now meeting the demand for inexpensive, noninvasive, and easy-to use diagnostic aids for oral and systemic diseases, and for assessing risk behaviors such as tobacco and alcohol use. Detection of HIV by the presence of virus-specific antibodies in saliva, for example, has led to the development of commercially available test kits . If increased numbers of certain salivary species are shown to be a signature of oral cancer, an early diagnostic test for OSCC may be developed, reducing the morbidity and mortality of this devastating cancer.
Studies to examine the validity of these findings are planned. If the results of this study are validated it will be important to address whether oral bacteria can be used as indicators of oral cancer and whether certain oral species contribute to carcinogenesis.
Results of the present study suggest that high salivary counts of C. gingivalis, P. melaninogenica and S. mitis may be diagnostic indicators of OSCC. These findings taken with those of an earlier study indicate that the presence of an OSCC has a more powerful effect on the salivary microbiota than either smoking or periodontal infections.
My sincere gratitude goes to Rosemary Costello RN, MS, OCN, and Julia Kazakin MD for their unwavering support of this study. Many thanks to James Rocco MD, PhD, Sovanda Som, BS, Tina Yaskell, BS, the staff of the Head and Neck Clinics at the Dana Farber Cancer Institute and Massachusetts General Hospital for their invaluable assistance in conducting this investigation. Finally, special thanks go to the patients who enrolled in this study; it would not have been possible without them.
- SEER: Cancer Statistics Review. 2002, US Department of Health and Human Services, Public Health Service, National Institutes of Health, Bethesda, MDGoogle Scholar
- The American Cancer Society. [http://www.cancer.org/docroot/home/index.asp]
- Silverman S: Oral cancer. Semin Dermatol. 2001, 13: 132-137.Google Scholar
- Canto MT, Devesa SS: Oral cavity and pharynx cancer incidence rates in the United States 1975–1998. Oral Oncol. 2002, 38: 610-617. 10.1016/S1368-8375(01)00109-9.View ArticlePubMedGoogle Scholar
- The Oral Cancer Foundation. [http://www.oralcancerfoundation.org/facts/]
- Mignogna MD, Fedele S, Russo LL: The World Cancer Report and the burden of oral cancer. Eur J Cancer Prev. 2004, 13: 139-142. 10.1097/00008469-200404000-00008.View ArticlePubMedGoogle Scholar
- Goldberg HI, Lockwood SA, Wyatt SW, Crossett LS: Trends and differentials in mortality from cancers of the oral cavity and pharynx in the United States, 1973–1987. Cancer. 1994, 74: 565-572.View ArticlePubMedGoogle Scholar
- Moore RJ, Doherty DA, Do KA, Chamberlain RM, Khuri FR: Racial disparity in survival of patients with squamous cell carcinoma of the oral cavity and pharynx. Ethn Health. 2001, 6: 165-77. 10.1080/13557850120078099.View ArticlePubMedGoogle Scholar
- Myers JN, Elkins T, Roberts D, Byers RM: Squamous cell carcinoma of the tongue in young adults: increasing incidence and factors that predict treatment outcomes. Otolaryngol Head Neck Surg. 2000, 122: 44-51.View ArticlePubMedGoogle Scholar
- Pitman KT, Johnson JT, Wagner RL, Myers EN: Cancer of the tongue in patients less than forty. Head Neck. 2000, 22: 297-302. 10.1002/(SICI)1097-0347(200005)22:3<297::AID-HED14>3.0.CO;2-3.View ArticlePubMedGoogle Scholar
- SEER: Cancer Statistics Review. 1998, US Department of Health and Human services, Public Health Service, National Institutes of Health, Bethesda, MDGoogle Scholar
- Neville BW, Day TA: Oral cancer and precancerous lesions. CA: Cancer J Clin. 2002, 52: 195-215.Google Scholar
- Silverman S: Demographics and occurrence of oral and pharyngeal cancers. The outcomes, the trends, the challenge. J Am Dent Assoc. 2001, 7-11. Suppl 132Google Scholar
- Holmes JD, Dierks EJ, Homer LD, Potter BE: Is detection of oral and oropharyngeal squamous cancer by a dental health care provider associated with a lower stage at diagnosis?. J Oral Maxillofac Surg. 2003, 61: 285-291. 10.1053/joms.2003.50056.View ArticlePubMedGoogle Scholar
- Alfano MC, Horowitz AM: Professional and community efforts to prevent morbidity and mortality from oral cancer. J Am Dent Assoc. 2001, 24S-29S. Suppl 132Google Scholar
- National Institute of Dental and Craniofacial Research. [http://www.nidr.nih.gov/HealthInformation/DiseaseAndConditions/spectrumSerie]
- Blot WJ, McLaughlin JK, Winn DM, Austin DF, Greenberg RS, Preston-Martin S, Bernstein L, Schoenberg JB, Stemhagen A, Fraumeni JF: Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res . 1988, 48: 3282-3287.PubMedGoogle Scholar
- Llewellyn CD, Johnson NW, Warnaulasuriya KA: Risk factors for squamous cell carcinoma of the oral cavity in young people – a comprehensive literature review. Oral Oncol. 2001, 37: 401-418. 10.1016/S1368-8375(00)00135-4.View ArticlePubMedGoogle Scholar
- Shugars DC, Patton LL: Detecting, diagnosing, and preventing oral cancer. Nurse Pract. 1997, 22: 105, 109-10. 113-5 passimView ArticleGoogle Scholar
- Thomas JE, Faecher RS: A physician's guide to early detection of oral cancer. Geriatrics. 1992, 47: 58-63.PubMedGoogle Scholar
- Hawkins RJ, Wang EE, Leake JL: Preventive health care, 1999 update: prevention of oral cancer mortality. The Canadian Task Force on Preventive Health Care. J Can Dent Assoc. 1999, 65: 617-PubMedGoogle Scholar
- Rice DH, Weimert TA: Altered bacterial flora and clinical course with intraoral cancer. Laryngoscope. 1978, 88: 1861-1863.PubMedGoogle Scholar
- Nagy KN, Sonkodi I, Szoke I, Nagy E, Newman HN: The microflora associated with human oral carcinomas. Oral Oncology. 1998, 34: 304-308. 10.1016/S1368-8375(98)00008-6.View ArticlePubMedGoogle Scholar
- Sasaki H, Ishizuka T, Muto M, Nezu M, Nakanishi Y, Inagaki Y, Watanabe H, Watanabe H, Terada M: Presence of Streptococcus anginosus DNA in esophageal cancer, dysplasia of esophagus, and gastric cancer. Cancer Research. 1998, 58: 2991-2995.PubMedGoogle Scholar
- Sakamoto H, Naito H, Ohta Y, Tanakna R, Maeda N, Sasaki J, Nord CE: Isolation of bacteria from cervical lymph nodes in patients with oral cancer. Archives of Oral Biology. 1999, 44: 789-793. 10.1016/S0003-9969(99)00079-5.View ArticlePubMedGoogle Scholar
- Tateda M, Shiga K, Saijo S, Sone M, Hori T, Yokoyama J, Matsuura K, Takasaka T, Miyagi T: Streptococcus anginosus in head and neck squamous cell carcinoma: implication in carcinogenesis. Int J Mol Med. 2000, 6: 699-703.PubMedGoogle Scholar
- Shiga K, Tateda M, Saijo S, Hori T, Sato I, Tateno H, Matsuura K, Takasaka T, Miyagi T: Presence of Streptococcus infection in extra-oropharyngeal head and neck squamous cell carcinoma and its implication in carcinogenesis. Oncol Rep. 2001, 8: 245-248.PubMedGoogle Scholar
- Crean S-J, Nair SP, Fardy M, Wilson M, Spratt D: Identification of bacterial DNA using PCR cloning within oral squamous cell carcinomas [abstract]. J Dent Res. 2002, 81: A364-Google Scholar
- Krasse B: The proportional distribution of Streptococcus salivarius and other streptococci in various parts of the mouth. Odont Revy. 1954, 5: 203-211.Google Scholar
- Liljemark WF, Gibbons RJ: Proportional distribution and relative adherence of Streptococcus mitis on various surfaces in the human oral cavity. Infect Immun. 1972, 6: 852-859.PubMed CentralPubMedGoogle Scholar
- Van Houte J, Gibbons RJ, Banghart SB: Adherence as a determinant of the presence of Streptococcus salivarius and Streptococcus sanguis on the human tooth surface. Arch Oral Biol. 1970, 15: 1025-1034. 10.1016/0003-9969(70)90115-9.View ArticlePubMedGoogle Scholar
- Van Houte J, Gibbons RJ, Pulkkinen AJ: Adherence as an ecological determinant for streptococci in the human mouth. Arch Oral Biol. 1971, 16: 1131-1141. 10.1016/0003-9969(71)90042-2.View ArticlePubMedGoogle Scholar
- Gibbons RJ, van Houte J: Dental caries. Annu Rev Med . 1975, 26: 121-136. 10.1146/annurev.me.26.020175.001005.View ArticlePubMedGoogle Scholar
- Gibbons RJ: Role of adhesion in microbial colonization of host tissues: a contribution of oral microbiology. J Dent Res. 1996, 75: 866-870.View ArticlePubMedGoogle Scholar
- Gibbons RJ: Bacterial adhesion to oral tissues: A model for infectious diseases. J Dent Res. 1989, 68: 750-760.View ArticlePubMedGoogle Scholar
- Neeser JR, Grafstrom RC, Woltz A, Brassart D, Fryder V, Guggenheim B: A 23 kDa membrane glycoprotein bearing NeuNAc alpha 2-3Gal beta 1-3GalNAc O-linked carbohydrate chains acts as a receptor for Streptococcus sanguis OMZ 9 on human buccal epithelial cells. Glycobiology . 1995, 5: 97-104.View ArticlePubMedGoogle Scholar
- Bhavanandan VP: Cancer-associated mucins and mucin-type glycoproteins. Glycobiology. 1991, 1: 493-503.View ArticlePubMedGoogle Scholar
- Hakomori S: Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res. 1996, 56: 5309-5318.PubMedGoogle Scholar
- Hoang-Vu C, Bull K, Schwarz I, Krause G, Schmutzler C, Aust G, Kohrle J, Dralle H: Regulation of CD97 protein in thyroid carcinoma. J Clin Endocrinol Metab. 1999, 84: 1104-1109. 10.1210/jc.84.3.1104.PubMedGoogle Scholar
- Tieng V, Le Bouguenec C, du Merle L, Bertheau P, Desreumaux P, Janin A, Charron D, Toubert A: Binding of Escherichia coli adhesin AfaE to CD55 triggers cell-surface expression of the MHC class I-related molecule MICA. Proc Natl Acad Sci. 2002, 99: 2977-2982. 10.1073/pnas.032668099.PubMed CentralView ArticlePubMedGoogle Scholar
- Williams P, Chaudhry Y, Goodfellow IG, Billington J, Powell R, Spiller OB, Evans DJ, Lea S: Mapping CD55 function. The structure of two pathogen-binding domains at 1.7 A. J Biol Chem. 2003, 278: 10691-10696. 10.1074/jbc.M212561200.View ArticlePubMedGoogle Scholar
- Mager DL, Ximenez-Fyvie LA, Haffajee AD, Socransky SS: Distribution of selected bacterial species on intra-oral surfaces. J Clin Periodontol. 2003, 30: 644-654. 10.1034/j.1600-051X.2003.00376.x.View ArticlePubMedGoogle Scholar
- Mager DL, Haffajee AD, Socransky SS: The effects of periodontitis and smoking on the microbiota of oral mucous membranes and saliva in systemically healthy subjects. J Clin Periodontol. 2003, 30: 1031-1037. 10.1046/j.0303-6979.2003.00418.x.View ArticlePubMedGoogle Scholar
- van der Velden U, Abbas F, Hart AA: Experimental gingivitis in relation to susceptibility to periodontal disease. (I.) Clinical observations. J Clin Periodontol. 1985, 12: 61-68.View ArticlePubMedGoogle Scholar
- Lie MA, Danser MM, van der Weijden GA, Timmerman MF, de Graaff J, van der Velden U: Oral microbiota in subjects with a weak or strong response in experimental gingivitis. J Clin Periodontol. 1995, 22: 642-647.View ArticlePubMedGoogle Scholar
- Muller H-P, Zoller L, Eger T, Hoffmann S, Lobinsky D: Natural distribution of oral Actinobacillus actinomycetemcomitans in young men with minimal periodontal disease. J Periodont Res. 1996, 31: 373-380.View ArticlePubMedGoogle Scholar
- Asikainen S, Chen C: Oral ecology and person-to-person transmission of Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. Periodontology 2000. 1999, 20: 65-81.View ArticlePubMedGoogle Scholar
- Danser MM, Timmerman MF, van Winkelhoff AJ, van der Velden U: The effect of periodontal treatment on periodontal bacteria on the oral mucous membranes. J Periodontol. 1996, 67: 478-485.View ArticlePubMedGoogle Scholar
- Lie MA, van der Weijden GA, Timmerman MF, Loos BG, van Steenbergen TJ, van der Velden U: Oral microbiota in smokers and non-smokers in natural and experimentally-induced gingivitis. J Clin Periodontol. 1998, 25: 677-686.View ArticlePubMedGoogle Scholar
- Colman G, Beighton D, Chalk AJ, Wake S: Cigarette smoking and the microbial flora of the mouth. Aust Dent J. 1976, 21: 111-118.View ArticlePubMedGoogle Scholar
- van Winkelhoff AJ, van der Velden U, Winkel EG, De Graaff J: Black-pigmented Bacteroides and motile organisms on oral mucosal surfaces in individuals with and without periodontal breakdown. J Perio Res. 1986, 21: 434-439.View ArticleGoogle Scholar
- Eger T, Zoller L, Muller H-P, Hoffmann S, Lobinsky D: Potential diagnostic value of sampling oral mucosal surfaces for Actinobacillus actinomycetemcomitans in young adults. Eur J Oral Sci. 1996, 104: 112-117.View ArticlePubMedGoogle Scholar
- Socransky SS, Smith C, Martin L, Paster BJ, Dewhirst FE, Levin AE: "Checkerboard" DNA-DNA hybridization. Biotechniques. 1994, 17: 788-792.PubMedGoogle Scholar
- Smith GL, Socransky SS, Smith CM: Rapid method for the purification of DNA from subgingival microorganisms. Oral Microbiol Immunol. 1989, 4: 47-51.View ArticlePubMedGoogle Scholar
- Feinberg AP, Vogelstein BA: Technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 1983, 132: 6-13. 10.1016/0003-2697(83)90418-9.View ArticlePubMedGoogle Scholar
- Schramm W, Angulo GB, Torres PC, Burgess-Cassler A: A simple saliva-based test for detecting antibodies to human immunodeficiency virus. Clin Diagn Lab Immunol. 1999, 6: 577-80.PubMed CentralPubMedGoogle Scholar
- Smith DJ, Anderson JM, King WF, Van Houte J, Taubman MA: Oral streptococcal colonization of infants. Oral Microbiol Immunol. 1993, 8: 1-4.View ArticlePubMedGoogle Scholar
- Krasse B: The proportional distribution of different types of streptococci in saliva and plaque material. Odont Revy. 1953, 4: 304-312.Google Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.